Navigation Links
Nature's elegant solution to repairing DNA in cancer, other conditions
Date:4/20/2011

DURHAM, N.C. A major discovery about an enzyme's structure has opened a window on understanding DNA repair. Scientists at Duke University Medical Center have determined the structure of a nuclease that will help scientists to understand several DNA repair pathways, a welcome development for cancer research.

DNA repair pathways are very important in the context of cancer biology and aging, but the tools the cell uses to do those repairs are not well understood.

"Until we saw the structure using X-ray crystallography, we didn't understand how it could recognize so many unusual DNA structures," said senior author Lorena Beese, Ph.D., James B. Duke Professor of Biochemistry. "The relative arrangement of the binding sites and of the active site itself for this enzyme is important for recognition during the repair process, and I don't think we could have imagined how it came together."

The study appears in this week's issue of Cell journal.

"We present the first structural information about these nucleases in humans, and that information is important for DNA substrate recognition and enzymatic mechanism," Beese said. "The discovery is important for understanding the mismatch repair pathway, and more generally, it will help us understand other pathways as well."

If mismatch repairs are not completed properly, this deficiency can have profound effects on human health, including genes that mutate spontaneously, forms of colorectal cancer, and the development of an estimated 15-25 percent of sporadic tumors, the authors noted.

"Scientists have been interested in obtaining a detailed picture of where the atoms are in this protein for a long time. We were able to determine the structure, because we put together the right experiments at the right time good protein expression, good purification, and fortunately when we got crystals we had the right team to solve the structure and do the biochemical experiments," Beese said. "This was truly a team effort."

The next step is to study complexes of this molecule with other proteins in the repair pathway. "By understanding the interactions between proteins, we will get more insight into how it works and how the activities are regulated," Beese said. "In terms of future therapeutic strategies, these interfaces present exciting targets for new drugs."

Also to be published in the April 14 issue of Cell, a team lead by John Tainer at the Lawrence Berkeley labs reports that another nuclease in a related pathway has the same structural arrangements.

"It's remarkable how nature has solved complex topological puzzles in DNA substrate recognition with such elegant simplicity," Beese said.


'/>"/>

Contact: Mary Jane Gore
mary.gore@duke.edu
919-660-1309
Duke University Medical Center
Source:Eurekalert

Related medicine news :

1. Digital Signatures Presented at Electronic Document Management Conference
2. Basque researchers apply chemistry to restoration of paintings and dating of signatures
3. Molecular Signatures in Post-Mortem Brain Tissue of Younger Individuals at High Risk for Alzheimer's Disease
4. Molecular signatures may aid fight against pediatric liver disease
5. SXC Health Solutions to Host Fiscal 2009 Fourth Quarter and Year End Results Conference Call
6. Senator Janis Lee Sponsors Senate Resolution Supporting Kevin Saunders for Chairman of the President's Council on Physical Fitness & Sports
7. University of Virginia Health System Medical Laboratories Selects Sunquest's Specimen Collection Solution
8. PHNS Implements New Accelerated Claims Resolution Services With iSoftStone
9. Virginia House Majority Leader Morgan Griffith Sponsors Legislation Enabling Mobile Solution for Health Care SALEM, Va.
10. Medibank Health Solutions: The New Name to Trust in Workplace Health
11. Beat The Odds and Get Back on Track; Revitalizing Fitness Training and Exercise Resolutions With Newly Released, Complimentary Video Series
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
Breaking Medicine Technology: